FFP-106

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFFP-106
Drug Alias NameFFP-106
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCD40 ligand inhibitorsTumor necrosis factor receptor superfamily member 5 inhibitors
TargetsCD40 ligandTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFast Forward Pharmaceuticals Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFast Forward Pharmaceuticals Bv
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A